Navigation Links
George Institute receives Gates Foundation grant to survey funding flows

A team of international health experts is launching a major study to track global funding for research and development (R&D) for neglected diseases in developing countries by surveying global public, private and philanthropic investments. As funding for R&D for neglected diseases has increased, donors do not have a complete overview of how much is currently being spent and on what diseases, which makes determining funding gaps difficult. The George Institute for International Health received a 5 year $US8.8 million grant from the Bill & Melinda Gates Foundation to collect and report global investment into R&D for neglected diseases.

Too often, global health funders must base substantial R&D investment decisions on out-of-date, unreliable information. They lack information about how much or where to invest, or how their investments sit in the context of overall funding flows and priorities, said Dr Mary Moran, Project Leader at the George Institute. By providing an updated and in depth overview, we hope to help donors around the world determine where their investments are most needed, and prevent duplication of effort she added.

Annually for a five year period, The George Institute will survey and analyse public and private global funders, intermediaries and developers, collecting data through an online survey. The survey will examine all aspects of product R&D funding from basic research, through discovery and development, to post-registration activities that support product introduction. It will measure R&D investment into new drugs, vaccines, diagnostics, microbicides and other tools for tropical diseases such as malaria and sleeping sickness, as well as developing-country strains of global diseases such as pneumonia, meningitis and HIV/AIDS, which are often overlooked by product developers that typically prioritize industrialized country markets.

We hope that better information about global funding for R&D for neglected diseases will encourage new investments, and help ensure they are targeted for maximum impact, said Dr. Regina Rabinovich, Director of Infectious Diseases Development at the Gates Foundation.

The project maintains The George Institutes focus on delivering quality public health outcomes. The George Institute for International Health is a multinational not-for-profit research organisation with offices in Australia, China, India and the United Kingdom. The Institute works towards improvement and development of global health through undertaking high quality research, and applying this research to health policy and practice. Given its widely acknowledged work on neglected disease product pipelines and funding, the Health Policy Division of the George Institute is uniquely placed to deliver such an important and vital project.


Contact: Emma Orpilla
Research Australia

Related medicine news :

1. Mothers Know Best: NFL Moms Team With Eddie George to Showcase a Better Way to a Healthier Lifestyle
2. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
3. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
4. George Mason University professor receives $2.6 million NIH grant to study Alzheimers disease
5. New USAID grant helps Georgetown meet unmet family planning needs worldwide
6. CNS Response, Inc. Appoints George C. Carpenter IV to Position of President
7. Reunion with patient inspires follow-up study on treatment for DiGeorge syndrome
8. Georgetown leads major effort to combat disparities in DC stroke care
9. Skinvisible Appoints Dr. George Korkos to Its Advisory Board
10. George Harrison Fund for UNICEF Announces Donation for Bangladesh Cyclone Relief
11. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: